Mylan appoints two new board members
PITTSBURGH — Mylan has appointed its president and a former Goldman Sachs & Co. partner to its board, the generic drug maker said Monday.
Mylan announced the appointment of president Rajiv Malik and former Goldman Sachs partner Melina Higgins to its board.
Malik has served in various leadership positions at Mylan since January 2007, when it acquired a controlling stake in India-based Matrix Labs Ltd., now known as Mylan Labs Ltd.; Malik was Matrix’s CEO at the time. Since then, Mylan said, he has helped expand and diversify the company’s global product portfolio, pipeline and manufacturing footprint.
Higgins worked for Goldman Sachs for nearly 20 years, starting there in 1989 and retiring in 2010. While there, she served as a member of the investment committee of the principal investment area, which oversaw and approved global private equity and private debt investments and was one of the largest alternative asset managers in the world. She also served as head of the Americas and as co-chairwoman of the investment advisory committee for the GS Mezzanine Partners funds, managing more than $30 billion of assets.
Bartell Drugs introduces PharmaSmart kiosks
SEATTLE — Bartell Drugs has introduced PharmaSmart blood-pressure testing kiosks at all 58 of its stores, the regional retail pharmacy chain said Monday.
Bartell said it was the first drug store chain in the Pacific Northwest to provide the new kiosks, made by Rochester, N.Y.-based PharmaSmart International.
"In this era of personalized medicine, the role of the pharmacist continues to expand as a healthcare provider," Bartell pharmacy professional services manager Billy Chow said. "The PharmaSmart kiosk technology is a valuable new frontline tool for blood-pressure prevention and management."
According to PharmaSmart, the company’s connectivity network has collected and stored more than 16 million patient readings to date in its Blood Pressure Tracker repository. The software allows pharmacists at Bartells to conduct timely reviews with patients who may have hypertension or be at risk of it.
According to the Centers for Disease Control and Prevention, hypertension was listed as a primary or contributing cause of death for about 348,000 Americans in 2008, and an estimated 1-in-3 American adults have the condition. Meanwhile, of the 68 million Americans with hypertension, 1-in-5 don’t know they have it, and 36 million don’t have their blood pressure under control.
Walgreens Infusion Services saves $850,000 in three-month period
DEERFIELD, Ill. — Home nutrition support team interventions improved patient care and potentially prevented an estimated 429 hospital days over a three-month period, at a cost savings of more than $850,000, according to new data presented by Walgreens Infusion Services at the American Society for Parenteral and Enteral Nutrition Clinical Nutrition Week meeting Monday in Phoenix.
“Dietitians are experts in nutrition support and play a vital role in home-delivered care,” stated Noreen Luszcz, Walgreens Infusion Services nutrition program director. “Our home nutrition support teams work together to proactively monitor patients’ therapy and provide regular updates to the patient’s physician. We invest in having dietitians as part of our teams because they play a vital role in providing appropriate, safe, cost-effective home nutrition support.”
The study included data from 16 Walgreens Infusion Services offices, with 2,500 enteral nutrition patients (who received their nutrition needs through a feeding tube) and 270 parenteral nutrition patients (who received their nutrition intravenously) on service during the study period. Interventions were performed by the Walgreens Infusion Services home nutrition support team, which includes nurses, pharmacists and dietitians who work closely with physicians to provide care to PN and EN patients.
This patient-centric multidisciplinary approach to care enabled the teams to quickly identify therapy complications and intervene to address them with the guidance of the physicians, Walgreens noted. There were 373 total interventions completed during the three-month study, including correcting over/underfeeding, preventing dehydration, reducing/eliminating diarrhea, managing hyperglycemia, managing electrolyte imbalances, transitioning patients from PN to oral eating, and starting patients on PN therapy in the home instead of in the hospital.
Patients are typically prescribed PN or EN because they cannot absorb an adequate amount of nutrients due to a health condition like cancer, a stroke or surgical complications. While both therapies can be administered in the hospital, about 40,000 PN patients and 344,000 EN patients each year receive their nutrition therapy at home, where they are more comfortable and can avoid the risk of exposure to hospital-acquired infections.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.